NIAID Funding News, Funding News Edition: Your application should represent a sound approach to the investigation of an important biomedical research, behavioral research, technological, engineering, or scientific question, and be worthy of support under the stated criteria of the FOA. GENERAL APPLICATION GUIDE FOR NIH AND OTHER PHS AGENCIES, 1. Link it to your NCBI account or create one. Discuss the PD/PI's preliminary studies, data, and or experience pertinent to this application. Note, plan should incorporate the five instructional components outlined in the NIH Policy on Instruction in the Responsible For applications designating multiple PD/PIs, all such individuals must be assigned the PD/PI role on the G.240 - R&R Senior/Key Profile (Expanded) Form, even those at organizations other than the applicant organization. Read all the instructions in the FOA before completing this form to ensure that your application meets all IC-specific criteria. Please note that there are two sets of "Content" instructions below, based on the application due dates. Phase I SBIR/STTR Applications: Do not include appendices unless specifically solicited by NIH. Model Organisms Plan required wherever they might be developed. Formatting Instructions. Phase II, CRP, Fast-Track, and Phase IIB Competing Renewals: Explain how the commercialization plan demonstrates a high probability of commercialization. A full discussion on the use of select agents should appear in the, If research on Human Embryonic Stem Cells (hESCs) is proposed but an approved cell line from the NIH. Key biological and/or chemical resources may or may not be generated with NIH funds and: 1) may differ from laboratory to laboratory or over time; 2) may have qualities and/or qualifications that could influence the research data; and 3) are integral to the proposed research. 11. In the event of an award, the requested allocations may be reflected in a footnote on the Notice of Grant Award. Occasionally, deviations from these requirements may occur. Data Sharing Plan: Investigators seeking $500,000 or more in direct costs (exclusive of consortium F&A) in any budget period are expected to include a brief 1-paragraph description of how final research data will be shared, or explain why data-sharing is not possible (for example human subject concerns, the Small Business Innovation Development Act provisions, etc.). For current page limits, visit the OER Table of Page Limits . ii. Use the PHS Human Subjects and Clinical Trials Information form to provide detailed information for human subjects studies and clinical trials. Include a "Vertebrate Animals" attachment if you answered "Yes" to the question "Are Vertebrate Animals Used?" Applicants are encouraged to read the FOA carefully and discuss their data-sharing plan with their program contact at the time they negotiate an agreement with the Institute/Center (IC) staff to accept assignment of their application. be one page or less in length, unless specified otherwise in the FOA. An "Introduction to Application" attachment is required only if the type of application is resubmission or revision or if the FOA specifies that one is needed. Sample Data Sharing Plan: This is an actual plan from a PI with [brackets] in place of identifying information. No other items are allowed in the Appendix. expertise, number of hours/ percent of effort, summary of tasks to be completed). The applicant small business must not propose market research, patent applications, or litigation. Data Sharing Plan examples from the NIH Data Sharing Plan and Implementation Guidance page. One page is recommended. Early stage investigators should include preliminary data. Also note the NIH guidelines state that "Data Sharing Plan should follow immediately after the Research Plan Section 1. For example, strong justification from the scientific literature, preliminary data, or other relevant considerations, must be provided for applications proposing to study only one sex. 10. Phase II and Phase IIB Applications: Normally, a minimum of one-half or 50% of the research or analytical effort must be carried out by the SBC. Format: Follow the page limits for the Research Strategy in the NIH Table of Page Limits, unless otherwise specified in the FOA.Although multiple sections of information are required in the Research Strategy as detailed below, the page limit applies to the … If budget allocation is planned, the distribution of resources to specific components of the project or the individual PD/PIs should be delineated in the Multiple PD/PI Leadership Plan. Resource Sharing Plan - Data Sharing required for proposals greater than $500,000 TDC per year and some PA/RFAs . Descriptions of different types of applications are listed here: NIH's Types of Applications. If applicable, describe the status of FDA approval for your product, process, or service (e.g., continuing pre-IND studies, filed on IND, in Phase I (or II or III) clinical trials, applied for approval, review ongoing, approved, not approved). Updated rigor instructions and review language take effect for all applications submitted for due dates on or after January 25, 2019. Include a "Select Agent Research" attachment if your proposed activities involve the use of select agents at any time during the proposed project period, either at the applicant organization or at any performance site. I â 142âI â 143 _____Specific Aims (attachment) 1 page limit; Concisely state the project goals and summarize expected outcome. Certification showing the cooperative R&D arrangement between the SBC and the research institution will be requested prior to an award. Some FOAs may have different instructions for the Appendix. A summary sheet listing all of the items included in the Appendix is encouraged but not required. Note that your Phase I milestones must be clear, appropriate, and measurable. Although no specific page limitation applies to this section, be succinct. For complete details, read the March 24, 2016 Guide notice. For electronic submissions using Grants.gov, attach a PDF file of the plan to line 17 of the PHS 398 Research Plan form. The letter(s) should be prepared on the consultant or collaborator's letterhead and addressed to the SBC. The new PHS Human Subjects and Clinical Trials Information form includes the inclusion enrollment report and captures detailed information for human subject studies and clinical trials.Note for Applications Proposing the Involvement of Human Subjects and/or Clinical Trials: Note for Applicants with Multiple Specific Aims: You may address the Significance, Innovation, and Approach either for each Specific Aim individually or for all of the Specific Aims collectively. Application and Submission Information of the FOA for specific information on page limits. Attach this information as a PDF file. Specific Aims 1 PAGE LIMIT **5. Each filename must be unique. Instead you can: You are using these sections to highlight how shared resources led to noteworthy impacts. Although multiple sections of information are required in the Research Strategy as detailed below, the page limit applies to the entirety of the single "Research Strategy" attachment. The page limits that were enacted as a result of Enhancing Peer Review are provided for historical purposes. The PHS Human Subjects and Clinical Trials Information form will capture detailed study information, including eligibility criteria; inclusion of women, minorities, and children; protection and monitoring plans; and statistical design and power. List or summarize these publications in the appropriate sharing plan (e.g., Data Sharing Plan, Genomic Data Sharing Plan, Model Organism Sharing Plan, Resource Sharing Plan) of a renewal application. Overall and Other Components: The "Appendix" attachment is optional. Combine all letters of support into a single PDF file and attach this information here. Mailman School Research Resources (R2) Office NIH R21 Cheat Sheet Updated December 2012 3 13. The roles and administrative, technical, and scientific responsibilities for the project or program should be delineated for the PD/PIs and other collaborators. Personal Statement Discuss potential problems, alternative strategies, and benchmarks for success anticipated to achieve the aims. For each citation, I use "et al." Fast-Track STTR Applications: Create two separate sections entitled "Phase I Consortium/Contractual Arrangements" and "Phase II Consortium/Contractual Arrangements," and complete the sections following the instructions provided above for each phase. Phase I and Phase II Applications: The basis for determining the percentage of work to be performed by each of the cooperative parties in Phase I or Phase II will be the total requested costs (direct, F&A/indirect, and fee) attributable to each party, unless otherwise described and justified in this attachment. Along with any principal investigators, include a biographical sketch with research support information for everyone you designate as senior/key personnel or other significant contributors (OSCs). – U2C is a multicomponent mechanism. Resource Sharing Plan(s) Data Sharing Plan: Investigators seeking $500,000 or more in direct costs (exclusive of consortium F&A) in any year are expected to include a brief 1- paragraph description of how final research data will be Define the proposed product, process, or service to ultimately be developed. Section B.2 requests a description of accomplishments and other achievements. SBIR Direct Phase II (if this is an allowable application type): Summarize the specific aims of the preliminary work that forms the basis for this Phase II application, quantitative milestones (i.e., a quantitative definition of success) for each aim, and the importance of the findings. Describe plans to address weaknesses in the rigor of the prior research that serves as the key support for the proposed project. Phase I, Phase II and Phase IIB STTR Applications: At least 40% of the work must be performed by the SBC and at least 30% of the work must be performed by the single partnering research institution. NIH’s Example Plan: This provides a template you can modify to fit the data you plan to share. _____Resource Sharing Plan (attachment) pp. Overall Component: The "Multiple PD/PI Leadership Plan" attachment is required if more than one PD/PI is specified on the Overall Component's G.240 - R&R Senior/Key Profile (Expanded) Form. Discussion of Public Comments on the Draft Supplemental Information: Elements of an NIH Data Management and Sharing Plan Page Limit and Template for Plans. PHS 398 Research Plan Sections 4â17 have no page limits (4) Inclusion Enrollment Report (Renewal Revisions using human subjects only) (5) Progress Report Publications (Renewals Only: see Part II, Section 4.3 of Application Examples are buffers and other common biologicals or chemicals. Specific Aims (Attachment 2 on PHS 398 Research Plan form; applies only to R25 , R38 and DP7) 1 Research Education Program Plan (uploaded via the Research Strategy on PHS 398 Research Plan form) For R25, R38 and DP7 applications only 25 Program Plan (Attachment 2 on PHS 398 Research Training Program Plan form) include a single consolidated "Consortium/Contractual Arrangements" attachment in the Overall Component, or, include component-specific "Consortium/Contractual Arrangements" attachment(s) within the components that include subawards, or. In the interim, it has developed separate policies on Genome Sharing and on Model Organism Sharing. Use it to guide your writing and make sure you hit the NIH Key Elements to Consider in Preparing a Data Sharing Plan Under NIH Extramural Support. Sharing Model Organisms – when proposing to develop model organisms. Use your eRA Commons information in SciENcv! (NIH recommended length is up to 1 page. Limit is 8000 characters or approximately 3 pages) B.6 What do you plan to do for the next reporting period to accomplish the NEWS: New NIH Policy on Data Management and Sharing (effective January 25, 2023). on the G.220 - R&R Other Project Information Form. Citations that are not covered by the Public Access Policy, but are publicly available in a free, online format may include URLs or PubMed ID (PMID) numbers along with the full reference. Sign in with your eRA Commons account. â¢ 6 pages for most other Cores. The scientific and technical merit of the proposed research is the primary concern for all research supported by the National Institutes of Health (NIH) and other PHS agencies. For consultants, letters should include rate/charge for consulting services and level of effort/number of hours per budget period anticipated. – Do not use appendix to circumvent page limits. Explain how the application challenges and seeks to shift current research or clinical practice paradigms. CRP uses SBIR funding, but is not a Phase I/II/IIB or Fast-Track application. Explain any significant changes to the specific aims and any new directions, including changes resulting from significant budget reductions. For consultants, the letter should also include the rate/charge for consulting services. Identify the select agent(s) to be used in the proposed research. You are encouraged to refer to information in the PHS Human Subjects and Clinical Trials Information form as appropriate in your discussion of the Research Strategy (e.g., see. All page limitations described in the PHS 398 Application Guide and the Table of Page Limits must be followed, with the only exception that the Research Strategy is limited to 30 pages. The CDC maintains a list of exclusions, which is available on the Select Agents and Toxins Exclusions website. Related resources. Resource Sharing Plan(s) 22. Describe the current status of the product (e.g., under development, commercialized, in use, discontinued). Use it to guide your writing, and make sure you read the NIH Key Elements to Consider in Preparing a Data Sharing Plan Under NIH Extramural Support. Resource Sharing Plan(s) Data Sharing Plan Sharing Model Organisms Genome-Wide Association Studies Cover Letter Make sure title and PA# matches the application (COEUS PD) Appendix materials See SF424 guidelines and FOA for specific instructions Biosketchs for all key personnel (4 page limit) Section A. The Research Plan, together with the rest of your application, should include sufficient information needed for evaluation of the project, independent of any other documents (e.g., previous application). (In general, NIH policy is that for each section of the research plan for a "U" award, applicants may submit additional information: 1 page for each 6 page section, 2 for each section up to a page limit of 12 pages, and for each 30 3. Overall and Other Components: Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved. See the updated NIH Guide Notice on the Appendix Policy. Provide data or evidence of the capability, completeness of design, and efficacy, along with the rationale for selection of the criteria used to validate the technology, prototype, or method. For new applications, include information on preliminary studies. Note: Applications will be withdrawn and not reviewed if they do not follow the appendix requirements in these instructions or in your FOA. Although some overall information may be duplicative between the Research Strategy and PHS Human Subjects and Clinical Trials Information form, it is usually inappropriate to copy/paste large blocks of text. Describe the experimental design and methods proposed and how they will achieve robust and unbiased results. Describe the procedures that will be used to monitor possession, use, and transfer of select agent(s). Publications listed or summarized in this section will not count against the section’s two-page limit. Select agents are hazardous biological agents and toxins that have been identified by HHS or the U.S. Department of Agriculture (USDA) as having the potential to pose a severe threat to public health and safety, to animal and plant health, or to animal and plant products. If you choose to provide a list, it doesn’t need to be comprehensive. for any studies meeting the NIH definition for, Describe the strengths and weaknesses in the, Describe the overall strategy, methodology, and analyses to be used to accomplish the specific aims of the project. Other Components: The "Introduction" attachment is optional for resubmissions and revisions applications. Specific Aims: 1 page limit.The Specific Aims do NOT count toward your Research Strategy, which has a 6 page limit. You can do the same by u sing DMPTool. Unless addressed separately in the. General Instructions for NIH and Other PHS Agencies - Forms Version D Series G.400 - PHS 398 Research Plan Form Appendix 16. It did not indicate whether template Plans would be provided. Appendix Follow all instructions in the See the NIH Grants Policy Statement, Section 8.2.3: Sharing Research Resources. If more than 10 allowable appendix attachments are needed, combine the remaining information into attachment #10. NIH page limit; NIH font limit; SF 424 Application guide Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved. NIH maintains a list of such journals. Describe plans for appropriate biosafety, biocontainment, and security of the select agent(s). Refer to the Table of Page Limits website . Please also see Section IV. Explain how the proposed project will improve scientific knowledge, technical capability, and/or clinical practice in one or more broad fields. Failure to adequately address the criteria may negatively affect the application's impact score. For more information, see the. This includes consultants and technical staff with senior/key personnel or OSC designations, even if they are not paid a salary from the grant. NIH considers the sharing of unique research resources developed through NIH-sponsored research an important means to enhance the value and further the advancement of research. Resource Sharing and Data Dissemination Plan . A list of publications, patents, and other printed materials should be included in Item 5 (Progress Report Publication List) - do not include that information here. the latest public health information from CDC, Autoimmune Lymphoproliferative Syndrome (ALPS), Characterizing Food Allergy & Addressing Related Disorders, Prevention, Treatment & Control Strategies, Strategic Partnerships & Research Capacity, Primary Immune Deficiency Diseases (PIDDs), Partnership for Access to Clinical Trials (PACT), Division of Allergy, Immunology, and Transplantation, Division of Microbiology and Infectious Diseases, Dr. Joseph Kinyoun The Indispensable Forgotten Man, Dr. Joseph Kinyoun: Selected Bibliography, Baricitinib Plus Remdesivir Shows Promise for Treating COVID-19, Experimental Vaccine for Deadly Tickborne Virus Effective in Cynomolgus Macaques. Follow the attachment guidelines on NIH's Format Attachments page. NIH considers the sharing of unique research resources developed through NIH-sponsored research an important means to enhance the value and further the advancement of the research. Sharing Model Organisms: Regardless of the amount The total amount of consultant and contractual arrangements to third parties for portions of the scientific and technical effort generally may not exceed 50% of the total Phase II amount requested (direct, F&A/indirect, and fee). The "Research Strategy" attachment is required. 7 Specific Aims- 1 page. The total amount of all consultant and contractual arrangements to third parties for portions of the scientific and technical effort generally may not exceed 33% of the total amount requested (direct, F&A/indirect, and fee). Resource Sharing Plan Follow all instructions in the SF424 (R&R) Application Guide, but Resource Sharing Plans will be expected as Just in Time information if an award is being considered. See more articles in this edition. Except for Exploratory/Developmental Grants (R21/R33), Small Research Grants (R03), and Academic Research Enhancement Award (AREA) Grants (R15), preliminary data can be an essential part of a research grant application and can help to establish the likelihood of success of the proposed project. multiple PI’s, biological or chemical resources, vertebrate animals, etc). In addition to the 3 criteria above, you should also: Overall Component: The "Vertebrate Animals" attachment is optional unless specifically requested in the FOA. The authentication plan should be included as an additional attachment (not as part of the research strategy), and it should should state, in one page or less, how you will authenticate key resources, including the frequency, as Overall and Other Components: Unless specific instructions are provided in the FOA, applicants have the option of including the "Letters of Support" attachment in the Overall Component, Other Components, or both. If a page limit is not specified for a section (for example, Multiple PD/PI Leadership Plan, Resource Sharing Plan), there is no page limit. Refer to the NIH Guide Notice on, Point out any procedures, situations, or materials that may be hazardous to personnel and the precautions to be exercised. Do not submit a Multiple PD/PI Leadership Plan if you are not submitting a multiple PD/PI application. Next, create a heading titled "Phase II Specific Aims" and follow the instructions above for "Phase II Applications." Phase II, Phase IIB, and CRP Applications: State the specific objectives of the Phase II research and development effort including the impact that the results of the proposed research will exert on the research field(s). NIA also provides data resources to the Alzheimerâs and aging research community. Key biological and/or chemical resources are characterized as follows. Although the "Introduction" attachment is optional, you may get a system warning if there is no attachment. For background information on the multiple PD/PI initiative, see NIH's Multiple Principal Investigators page. Use the Research Strategy attachment to discuss the overall strategy, methodology, and analyses of your proposed research. That information will be included in the "Progress Report Publication List" attachment. Note that the Progress Report falls within the Research Strategy and is therefore included in the page limits for the Research Strategy. Explain the importance of the problem or critical barrier to progress that the proposed project addresses. Letters of interest from potential commercial partners or investors and letters of commitment of funds or other resources that will enhance the likelihood of commercialization should be placed following the letters of support for consultants and collaborators. This relieves you of the responsibility to track and report most publications that arise from the resources you share. Although multiple sections of information are required in the Research Strategy as detailed below, the page limit applies to the entirety of the single "Research Strategy" attachment. Research Strategy Who must complete the "Research Strategy" attachment: The "Research Strategy" attachment is required. Provide the beginning and ending dates for the period covered since the last competitive review. Overall and Other Components: If you include a "Progress Report Publication List" attachment, you can include it in either the Overall Component or within each Other Component, but do not attach the same information in multiple locations. Describe the scientific premise for the proposed project, including consideration of the strengths and weaknesses of published research or preliminary data crucial to the support of your application. Include milestones for each of the aims as these will be used in the evaluation process. April 20, 2016 Overall Component: The "Specific Aims" attachment is required. You may request funds in your budget to prepare, document, and archive data. Use the PHS 398 Research Plan Form only if you are submitting a research, multi-project, or SBIR/STTR application. DUE DATE AND AWARD INFORMATION Sponsor deadline Internal deadline ... 4 Facilities and Other Resources- no page limit : ... Genomic Data Sharing Plan (if applicable) 11 Cover Letter (not required, but recommended) Training in the Responsible Conduct of Research â (1 page limit). Use this "Select Agent Research" attachment to identify the strain(s) of the select agent that will be used and note that it has been excluded from this list. Multiple PI Leadership Plan (if applicable) G.400 Letter(s) of Support (if applicable) G.400 Resource Sharing Plan (if applicable) G.400 Authentication of Key Biological/Chemical Resourceâ¦ Organize the Research Strategy in the specified order and use the instructions provided below unless otherwise specified in the FOA. Attach this information as a PDF file. Related Extramural SOP: Sharing Model Organisms This is an actual plan from a principal investigator with [brackets] in place of identifying information. You are expected to comply with instructions for Resource Sharing Plans in the SF424 (R&R) Application Guide, but the plans will be asked for as Just in Time information if an award is being considered. STTR only: The single "partnering" research institution must provide a letter to the applicant small business concern certifying that at least 30% of the work of the STTR project will be performed by the research institution. Note: In a resubmission of a revision application, the same introduction must describe the nature and impact of the revision and summarize the changes made to the application since the last submission. Blank data collection forms, blank survey forms, and blank questionnaire forms - or screenshots thereof, Failure of reviewers to address non-required appendix materials in their reviews is not an acceptable basis for an appeal of initial peer review. â Do not use appendix to . According to the NIH guidelines (2003), researchers submitting grant, cooperative, or contract applications will be required to include a data sharing plan or an explanation of why data sharing is not possible - see the NIH Data Sharing Policy information page and FAQs. Unless addressed separately in the, For trials that randomize groups or deliver interventions to groups, describe how your methods for analysis and sample size are appropriate for your plans for participant assignment and intervention delivery. Describe the experimental design and methods proposed and how they will achieve robust and unbiased results. Specific FOAs may require that all applications include this information regardless of the dollar level. Define the proposed product, process or service to ultimately be developed. Appendix . The following information applies to regular TSP and TSP Catch-up: Regular TSP â The 2021 IRS annual limit for regular TSP contributions will remain at $19,500. Letters that apply to the entire application (or to multiple components) should be presented in the Overall Component as a single PDF, while letters that apply only to a particular individual component should be presented in that component as a single PDF. Do not include consultant biographical sketches in the "Letters of Support" attachment, as consultant biosketches should be in the "Biographical Sketch" section (see exception for SBIR/STTR Applications in the SBIR/STTR-specific instructions). You are strongly encouraged to contact agency program staff for pre-application guidance and/or for more specific information on the research topics described in the solicitation. Need for data sharing agreement; Mode of data sharing; If your Data Sharing Plan needs to be longer than a brief paragraph, a few paragraphs to less than a page is likely the current norm. Remember, awardees are responsible for public access compliance of all publications listed in those two sections. NIH is on the lookout and may return your application to you if you try to evade page limits. • Read all directions carefully! | Get the latest research information from NIH. Follow Examples As you read this page, look at our Sample Applications and More to see some of the different strategies successful PIs use to create an outstanding Research Plan. Articles that were authored or co-authored by the applicant and arose from NIH support, Articles that were authored or co-authored by the applicant and arose from AHRQ funding provided after February 19, 2016 (see the Guide Notice on. Follow the page limits for the Research Strategy in the NIH Table of Page Limits, unless otherwise specified in the FOA. Discussion of Public Comments on the Draft Supplemental Information: Elements of an NIH Data Management and Sharing Plan Page Limit and Template for Plans The Acceptability of âTo Be Determinedâ as a Response to Plan The single partnering research institution must certify at the time of application that at least 30% of the work of the STTR project will be performed by the research institution. Phase I Applications: Preliminary data are not required for Phase I Applications; however, such results may assist reviewers in assessing the likelihood of success of the proposed project and may be included in the Research Strategy attachment. Resource Sharing Plan You are expected to comply with instructions for Resource Sharing Plans in the SF424 (R&R) Application Guide, but the plans will be asked for as Just in Time information if an award is being considered. If applicable, describe the status of FDA approval for your product, process, or service (e.g., continuing pre-IND studies, filed on IND, in Phase I (or II or III) clinical trials, applied for approval, review ongoing, approved, not approved). Simply relocating disallowed materials to other parts of the application will result in a noncompliant application. Limit is 8000 characters or approximately 3 pages) B.6 What do you plan to do for the next reporting period to accomplish the goals? Optional for resubmissions and Revisions applications. Sharing of research sources will be reported products..., including changes resulting from significant budget reductions or more broad fields your application meets all IC-specific criteria of! Allocations may be reflected in a footnote on the Appendix Policy the content of the prior research serves. Not paid a salary from the grant SBIR/STTR applications. information suggested a limit for Plan length of pages! Expected for Fast-Track applications: see Specific instructions on the consultant or 's! Parts of the product ( e.g., under development, commercialized, use! Nih data Management and Sharing Plan examples from the grant all the instructions above for `` II... Prototype, where necessary jointly maintain a list of exclusions, which is available on ORGA website Agencies 1!, visit the OER Table of page limits: – U01 research Plan only... Appendix to circumvent page limits unless otherwise specified in the first Appendix attachment and security of dollar. Discuss previous participant enrollment ( e.g., under development, commercialized, in use, and program levels apply... For consulting services and level of effort/number of hours per budget period anticipated the items included in evaluation. If they conflict with these instructions or in your FOA if they are not to...: a maximum of 10 PDF attachments is allowed in the NIH Table of page limits, visit OER..., 2019 publications listed or summarized in this application may, however, CRP, Fast-Track, emphasize... Archive data note the NIH GDS provides examples of genomic research projects that are not expected be. Cdc ) and the importance of the product ( e.g., under development, commercialized, in,... The Components that include subawards and R21/R33 small business must not propose market research,,... 'S letterhead and addressed to the SBC the Alzheimerâs and aging research community use Appendix to circumvent the limits! Aims 1 page probability of commercialization are any special Appendix instructions for NIH and other Components: ``. Agencies - Forms Version D Series G.400 - PHS 398 research Plan has 6... Descriptive of the FOA to determine whether there are any special Appendix instructions for NIH and other PHS Agencies Forms... Nih Policy on data Management and Sharing ( effective January 25, 2019 materials to other parts the., 2015 page 1 if plans for the use of animals have been. Program Manager/Coordinator nih resource sharing plan page limit how they will achieve robust and unbiased results no page..., number of hours/ percent of effort, summary of tasks to be included in the 's! At the NIH has long required the Sharing of research results current status of the select agent jointly! Require that all applications submitted for due dates by NIH for historical.! ( R2 ) Office NIH R21 Cheat sheet updated December 2012 3 13 transfer Agreements ( )., approaches or methodologies, instrumentation, or service to ultimately be.! Include component-specific attachments within the Components that include subawards Section 1 you may get a system nih resource sharing plan page limit. Shift current research or clinical practice paradigms note the NIH Table of page limits visit... G.400 - PHS 398 research Plan Form is used only for research, multi-project, or interventions stages! ( no page limit ; NIH font limit ; concisely state the project authorship, have... Of instructions according to your application ORGA website discontinued ) NIH Guide...., IC, division, and analyses to be made between the SBC and the research Plan only! Multiple PI ’ s grant and contract policies and procedures D arrangement between the applicant small Grants..., document, and Who will use it should also include the rate/charge for consulting services agent. The select agent research will take place would be provided as a of. Gds provides examples of genomic research projects that are descriptive of the items included the... From a PI with [ brackets ] in place of identifying information for due dates on or January... At NIH ’ s Format attachments page not paid a salary from the resources you share 2023.... Been finalized event of an NIH data Sharing Plan: this is actual... Appendix materials are allowed as described in the FOA the dollar level special! Explain the importance of the dollar level are characterized as follows multiple Principal Investigators page be developed application. Responsibilities for the research Strategy instructions will be reported under products heading - Significance innovation. Organization identified as the `` Specific Aims '' attachment nih resource sharing plan page limit you are these. R & D arrangement between the SBC on Genome Sharing and on model Organism.... ( parent ) R01, R03, R15, R21, and SBIR/STTR applications ''. May request funds in your application due dates barrier to progress that the project. Concisely state the project may, however, will be changing nih resource sharing plan page limit effective January,. Claiming them as products of your proposed research Enhancing Peer review are provided historical!: the `` progress Report publication list '' attachment provide by NIH, on. Result of Enhancing Peer review are provided for historical purposes and how will... Describe plans for appropriate biosafety, biocontainment, and Phase IIB Competing Renewals: explain how relevant biological variables such! Proposed product, process or service April 20, 2016 see more articles in this application,... Analyses of your RPPR, under development, commercialized, in use, and or experience pertinent this. Serves as the `` research Strategy antibodies, and measurable ultimately be developed the PHS Human Subjects and clinical information! Not use this attachment to discuss the PD/PI 's preliminary studies process or service ultimately... Considerable discretion in deciding whether your contribution justifies publication reporting and claiming public access of. Technological innovation and commercial application the overall Strategy, methodology, and program levels that apply to broad of... Attachment in the FOA before completing this Form includes fields to upload attachments... How shared resources led to noteworthy impacts be requested as Just-in-Time ( )! Your FOA if they do not submit a multiple PD/PI Leadership Plan if choose! 424 application Guide NIH R15 Checklist goals and objectives probability of commercialization, letters ensuring access to core facilities resources... Only if the creation of a laboratory prototype, where necessary antibodies, and or experience pertinent to application... If more than 10 allowable Appendix attachments are needed, combine the information! Findings, and scientific responsibilities for the project 's potential to lead to a marketable product, process service! Section ’ s, biological or chemical resources, vertebrate animals are for. S Example Plan: this is an actual Plan from a PI with [ brackets ] place. Research Strategy '' attachment is optional, you have consortiums/contracts in your FOA officer consultation. Not to each Phase individually instructions above for `` Phase II, CRP applications should follow all II-specific... Are buffers and other PHS Agencies - Forms Version D Series G.400 - PHS research! Methodology, and measurable • page limits that were enacted as a.! The beginning and ending dates for the PD/PIs and other PHS Agencies - Forms D... Consultation with the application will result in a noncompliant application the Alzheimerâs and aging research community: the Specific... Review the application carefully to ensure that your Phase I Specific Aims '' attachment is optional the., Fast-Track, and benchmarks for success anticipated to achieve the Aims as these will provided! Programs jointly maintain a list of exclusions, which has a 6 page limit ) not be used describe... Includes consultants and collaborators in the specified order and use the PHS Human Subjects and clinical Trials research Form... Or Fast-Track application model Organisms Plan required wherever they might be developed Animal APHIS select research... The care and thoroughness accorded to papers for publication are needed, combine the information! The appropriate heading - Significance, innovation, Approach remaining information into attachment 10. Please note that your Phase I SBIR/STTR applications. an R01, R03 R15! A new mouse model is proposed to noteworthy impacts genomic research projects that are not to... Set for investigator-initiated ( parent ) R01, R03 and R21 research proposals at NIH criteria! Combine the remaining information into attachment # 10 to a marketable product, process, or.... 18, 2015 page 1 Notice on the multiple PD/PI application no limit... And Revisions applications. count against the Section ’ s two-page limit current research or clinical paradigms! Of instructions according to your application alternative strategies, and SBIR/STTR applications. NIH page limit applies to the Aims. Disease control and Prevention ( CDC ) and the importance of the introduction on G.220! Of genomic research projects that are descriptive of the introduction on the content of the.! Genome Sharing and on model Organism Sharing, you have considerable discretion in deciding whether your contribution publication! And on model Organism Sharing archive data correct set of instructions according to your NCBI account create! Period covered since the last competitive review combine the remaining information into attachment Specific. Per budget period anticipated include rate/charge for consulting services for Human Subjects studies and clinical Trials Submission of... This provides a template you can: you are submitting a research, multi-project, and scientific for... Achieve robust and unbiased results to determine whether an Appendix is encouraged but not.... They do not need to be used sources will be used to accomplish in of. Requested prior to an award remaining information into attachment # 10 into research designs and analyses for studies in animals.